Metabolomic Signatures Differentiate Patients With vs Without IBS
Twelve fecal metabolites are significantly altered among patients with irritable bowel syndrome compared with healthy control individuals.
Individuals with irritable bowel syndrome (IBS) have distinct metabolomic differences from those without the condition.
A study presented at the American College of Gastroenterology (ACG) 2025 conference found 12 metabolites that may affect IBS's pathophysiology.
Researchers conducted a systematic review and meta-analysis of 3903 studies, with 6 meeting inclusion criteria, published between 2011 and 2022.
- Case-control studies: 5
- Prospective observational studies: 1
Autor's summary: IBS patients have distinct metabolomic signatures.
More News
- Life Story: Raymond Frank Hills, 94; ‘Mayor’ Of East Millstone - The Franklin Reporter & Advocate
- Best Moments from the Opening of the Grand Egyptian Museum
- Joao Pedro Guides Chelsea Past Lacklustre Tottenham in Fiery Derby
- Huda Mustafa's Before And After Pics Surface, Had Cosmetic Procedures Before Joining 'Love Island'
- 2025 Breeders' Cup Saturday racing picks, odds, entries, results and more | Kentucky Derby
- Owls hope to move past semifinal shortcomings in 2025-26 season
- WTA News: WTA roundup: Victoria Mboko reaches Hong Kong final